| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | HAUS7 RAE1 NRCAM MAP1A MAP2 MAP6 SYNE1 TTLL5 ARFGEF1 NEB FMNL2 JAKMIP2 YWHAH KIF20A SETD2 CLMN CCSER2 PPP1R9B YWHAQ AGTPBP1 | 8.43e-06 | 1099 | 120 | 20 | GO:0008092 |
| GeneOntologyMolecularFunction | tubulin binding | HAUS7 RAE1 MAP1A MAP2 MAP6 TTLL5 JAKMIP2 KIF20A SETD2 CCSER2 YWHAQ AGTPBP1 | 1.05e-05 | 428 | 120 | 12 | GO:0015631 |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-nitrogen bonds | 1.64e-05 | 53 | 120 | 5 | GO:0016879 | |
| GeneOntologyMolecularFunction | carbamoyl-phosphate synthase (ammonia) activity | 3.58e-05 | 2 | 120 | 2 | GO:0004087 | |
| GeneOntologyMolecularFunction | carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 3.58e-05 | 2 | 120 | 2 | GO:0004088 | |
| GeneOntologyMolecularFunction | microtubule binding | 1.03e-04 | 308 | 120 | 9 | GO:0008017 | |
| GeneOntologyMolecularFunction | ligase activity | 6.46e-04 | 174 | 120 | 6 | GO:0016874 | |
| GeneOntologyCellularComponent | primary dendrite | 1.95e-04 | 4 | 120 | 2 | GO:0150001 | |
| GeneOntologyCellularComponent | costamere | 2.62e-04 | 22 | 120 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | microtubule associated complex | 3.37e-04 | 161 | 120 | 6 | GO:0005875 | |
| GeneOntologyCellularComponent | nuclear periphery | 4.64e-04 | 171 | 120 | 6 | GO:0034399 | |
| GeneOntologyCellularComponent | axon initial segment | 6.04e-04 | 29 | 120 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | cerebellar granule cell to Purkinje cell synapse | 6.73e-04 | 7 | 120 | 2 | GO:0150048 | |
| GeneOntologyCellularComponent | dendritic branch | 6.73e-04 | 7 | 120 | 2 | GO:0044307 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | CYLD MAP6 SYNE1 ARFGEF1 MCM3 CMYA5 YWHAZ ITPR1 PER2 UNC45B PLA2G4A YWHAQ DOCK6 HSP90AB3P | 9.41e-04 | 934 | 120 | 14 | GO:0048471 |
| GeneOntologyCellularComponent | microtubule | CYLD HAUS7 MAP1A INCENP MAP2 MAP6 TTLL5 KIF20A DYNC1LI1 YWHAQ | 1.01e-03 | 533 | 120 | 10 | GO:0005874 |
| GeneOntologyCellularComponent | supramolecular fiber | CYLD HAUS7 MAP1A INCENP MAP2 MAP6 SYNE1 TTLL5 CMYA5 NEB KIF20A UNC45B AHNAK DYNC1LI1 YWHAQ AHNAK2 | 1.16e-03 | 1179 | 120 | 16 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | CYLD HAUS7 MAP1A INCENP MAP2 MAP6 SYNE1 TTLL5 CMYA5 NEB KIF20A UNC45B AHNAK DYNC1LI1 YWHAQ AHNAK2 | 1.24e-03 | 1187 | 120 | 16 | GO:0099081 |
| GeneOntologyCellularComponent | nuclear matrix | 1.29e-03 | 140 | 120 | 5 | GO:0016363 | |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 1.74e-03 | 11 | 120 | 2 | GO:0034992 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 1.74e-03 | 11 | 120 | 2 | GO:0034993 | |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 1.74e-03 | 11 | 120 | 2 | GO:0106083 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 1.74e-03 | 11 | 120 | 2 | GO:0106094 | |
| Domain | 14_3_3 | 8.23e-06 | 7 | 117 | 3 | SM00101 | |
| Domain | 1433_1 | 8.23e-06 | 7 | 117 | 3 | PS00796 | |
| Domain | 1433_2 | 8.23e-06 | 7 | 117 | 3 | PS00797 | |
| Domain | 14-3-3_domain | 8.23e-06 | 7 | 117 | 3 | IPR023410 | |
| Domain | 14-3-3_CS | 8.23e-06 | 7 | 117 | 3 | IPR023409 | |
| Domain | 14-3-3 | 8.23e-06 | 7 | 117 | 3 | PF00244 | |
| Domain | 14-3-3 | 1.31e-05 | 8 | 117 | 3 | IPR000308 | |
| Domain | CarbamoylP_synth_ssu | 3.89e-05 | 2 | 117 | 2 | IPR006274 | |
| Domain | CarbamoylP_synth_lsu | 3.89e-05 | 2 | 117 | 2 | IPR006275 | |
| Domain | CPSase_sm_chain | 3.89e-05 | 2 | 117 | 2 | SM01097 | |
| Domain | CPSase_L_D3 | 3.89e-05 | 2 | 117 | 2 | SM01096 | |
| Domain | CbamoylP_synth_lsu_CPSase_dom | 3.89e-05 | 2 | 117 | 2 | IPR005483 | |
| Domain | CarbamoylP_synth_lsu_oligo | 3.89e-05 | 2 | 117 | 2 | IPR005480 | |
| Domain | CPSase_sm_chain | 3.89e-05 | 2 | 117 | 2 | PF00988 | |
| Domain | CPSase_L_D3 | 3.89e-05 | 2 | 117 | 2 | PF02787 | |
| Domain | - | 3.89e-05 | 2 | 117 | 2 | 3.50.30.20 | |
| Domain | - | 3.89e-05 | 2 | 117 | 2 | 1.10.1030.10 | |
| Domain | CarbamoylP_synth_ssu_N | 3.89e-05 | 2 | 117 | 2 | IPR002474 | |
| Domain | MGS-like_dom | 1.16e-04 | 3 | 117 | 2 | IPR011607 | |
| Domain | MGS | 1.16e-04 | 3 | 117 | 2 | PF02142 | |
| Domain | MGS | 1.16e-04 | 3 | 117 | 2 | SM00851 | |
| Domain | - | 1.16e-04 | 3 | 117 | 2 | 3.40.50.1380 | |
| Domain | ATP_grasp_subdomain_1 | 1.83e-04 | 18 | 117 | 3 | IPR013815 | |
| Domain | GATase | 3.84e-04 | 5 | 117 | 2 | PF00117 | |
| Domain | CPSASE_1 | 3.84e-04 | 5 | 117 | 2 | PS00866 | |
| Domain | GATASE_TYPE_1 | 5.74e-04 | 6 | 117 | 2 | PS51273 | |
| Domain | GATASE | 5.74e-04 | 6 | 117 | 2 | IPR017926 | |
| Domain | CPSASE_2 | 5.74e-04 | 6 | 117 | 2 | PS00867 | |
| Domain | PLA2_B | 8.00e-04 | 7 | 117 | 2 | PF01735 | |
| Domain | PLA2C | 8.00e-04 | 7 | 117 | 2 | PS51210 | |
| Domain | CbamoylP_synth_lsu-like_ATP-bd | 8.00e-04 | 7 | 117 | 2 | IPR005479 | |
| Domain | BC-like_N | 8.00e-04 | 7 | 117 | 2 | IPR005481 | |
| Domain | Ca_chan_IQ | 8.00e-04 | 7 | 117 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 8.00e-04 | 7 | 117 | 2 | PF08763 | |
| Domain | LysoPLipase_cat_dom | 8.00e-04 | 7 | 117 | 2 | IPR002642 | |
| Domain | VDCC_a1su_IQ | 8.00e-04 | 7 | 117 | 2 | IPR014873 | |
| Domain | CPSase_L_D2 | 8.00e-04 | 7 | 117 | 2 | PF02786 | |
| Domain | GPHH | 8.00e-04 | 7 | 117 | 2 | PF16905 | |
| Domain | GPHH_dom | 8.00e-04 | 7 | 117 | 2 | IPR031649 | |
| Domain | Biotin_carb_N | 8.00e-04 | 7 | 117 | 2 | PF00289 | |
| Domain | PLAc | 8.00e-04 | 7 | 117 | 2 | SM00022 | |
| Domain | ATP_grasp_subdomain_2 | 9.48e-04 | 31 | 117 | 3 | IPR013816 | |
| Domain | EPL1 | 1.06e-03 | 8 | 117 | 2 | PF10513 | |
| Domain | Enhancer_polycomb-like_N | 1.06e-03 | 8 | 117 | 2 | IPR019542 | |
| Domain | ZF_CCHC | 1.35e-03 | 35 | 117 | 3 | PS50158 | |
| Domain | - | 1.69e-03 | 10 | 117 | 2 | 3.40.50.880 | |
| Domain | VDCCAlpha1 | 1.69e-03 | 10 | 117 | 2 | IPR002077 | |
| Domain | Class_I_gatase-like | 2.46e-03 | 12 | 117 | 2 | IPR029062 | |
| Domain | - | 2.90e-03 | 13 | 117 | 2 | 3.40.50.20 | |
| Domain | ATP_GRASP | 3.37e-03 | 14 | 117 | 2 | PS50975 | |
| Domain | ATP-grasp | 3.37e-03 | 14 | 117 | 2 | IPR011761 | |
| Domain | PreATP-grasp_dom | 3.37e-03 | 14 | 117 | 2 | IPR016185 | |
| Domain | - | 3.87e-03 | 15 | 117 | 2 | 3.30.1490.20 | |
| Domain | ZnF_C2HC | 4.96e-03 | 55 | 117 | 3 | SM00343 | |
| Domain | Znf_CCHC | 4.96e-03 | 55 | 117 | 3 | IPR001878 | |
| Domain | Acyl_Trfase/lysoPLipase | 4.98e-03 | 17 | 117 | 2 | IPR016035 | |
| Domain | ARM-type_fold | 5.51e-03 | 339 | 117 | 7 | IPR016024 | |
| Domain | - | 5.58e-03 | 18 | 117 | 2 | 3.30.470.20 | |
| Pathway | REACTOME_G2_M_CHECKPOINTS | 2.25e-05 | 143 | 84 | 7 | MM15383 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 3.28e-05 | 271 | 84 | 9 | MM15388 | |
| Pathway | REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA | 4.32e-05 | 12 | 84 | 3 | MM14482 | |
| Pathway | REACTOME_SARS_COV_2_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS | 4.32e-05 | 12 | 84 | 3 | M45022 | |
| Pathway | REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX | 4.32e-05 | 12 | 84 | 3 | MM15443 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_ERK_SIGNALING_PATHWAY | 5.59e-05 | 13 | 84 | 3 | M47589 | |
| Pathway | REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX | 5.59e-05 | 13 | 84 | 3 | M27708 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 5.71e-05 | 291 | 84 | 9 | M16647 | |
| Pathway | REACTOME_G2_M_CHECKPOINTS | 6.08e-05 | 167 | 84 | 7 | M19381 | |
| Pathway | REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA | 8.82e-05 | 15 | 84 | 3 | M26902 | |
| Pathway | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | 9.10e-05 | 40 | 84 | 4 | MM14473 | |
| Pathway | REACTOME_SARS_COV_1_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS | 1.08e-04 | 16 | 84 | 3 | M46428 | |
| Pathway | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | 1.56e-04 | 18 | 84 | 3 | MM14510 | |
| Pathway | PID_LKB1_PATHWAY | 1.72e-04 | 47 | 84 | 4 | M87 | |
| Pathway | REACTOME_CELL_CYCLE | HAUS7 RAE1 INCENP ORC6 SYNE1 PSMC1 MCM3 YWHAH YWHAZ KIF20A PSME4 DYNC1LI1 YWHAQ | 2.20e-04 | 694 | 84 | 13 | M543 |
| Pathway | REACTOME_CELL_CYCLE | HAUS7 RAE1 INCENP ORC6 PSMC1 MCM3 YWHAH YWHAZ KIF20A PSME4 DYNC1LI1 YWHAQ | 2.27e-04 | 603 | 84 | 12 | MM14635 |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.42e-04 | 147 | 84 | 6 | MM15854 | |
| Pathway | WP_17P133_YWHAE_COPY_NUMBER_VARIATION | 2.51e-04 | 21 | 84 | 3 | M48088 | |
| Pathway | PID_P38_MK2_PATHWAY | 2.51e-04 | 21 | 84 | 3 | M199 | |
| Pathway | REACTOME_PROGRAMMED_CELL_DEATH | 2.60e-04 | 211 | 84 | 7 | M27436 | |
| Pathway | PID_NFAT_3PATHWAY | 2.75e-04 | 53 | 84 | 4 | M113 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.79e-04 | 151 | 84 | 6 | M39329 | |
| Pathway | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | 3.17e-04 | 55 | 84 | 4 | M7455 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | 3.32e-04 | 23 | 84 | 3 | MM15216 | |
| Pathway | PID_INSULIN_GLUCOSE_PATHWAY | 4.81e-04 | 26 | 84 | 3 | M247 | |
| Pathway | REACTOME_APOPTOSIS | 6.90e-04 | 179 | 84 | 6 | M15303 | |
| Pathway | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | 7.38e-04 | 30 | 84 | 3 | M17814 | |
| Pathway | WP_CELL_CYCLE | 7.42e-04 | 120 | 84 | 5 | M39650 | |
| Pathway | REACTOME_ORC1_REMOVAL_FROM_CHROMATIN | 7.55e-04 | 69 | 84 | 4 | MM15366 | |
| Pathway | REACTOME_ORC1_REMOVAL_FROM_CHROMATIN | 8.41e-04 | 71 | 84 | 4 | M4138 | |
| Pathway | KEGG_CELL_CYCLE | 8.93e-04 | 125 | 84 | 5 | M7963 | |
| Pathway | PID_PI3KCI_AKT_PATHWAY | 1.16e-03 | 35 | 84 | 3 | M249 | |
| Pathway | REACTOME_HYDROLYSIS_OF_LPC | 1.23e-03 | 9 | 84 | 2 | M26960 | |
| Pathway | REACTOME_HYDROLYSIS_OF_LPC | 1.23e-03 | 9 | 84 | 2 | MM14582 | |
| Pathway | PID_PI3K_PLC_TRK_PATHWAY | 1.26e-03 | 36 | 84 | 3 | M271 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 1.32e-03 | 80 | 84 | 4 | M223 | |
| Pathway | REACTOME_PROGRAMMED_CELL_DEATH | 1.58e-03 | 142 | 84 | 5 | MM15178 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 1.86e-03 | 11 | 84 | 2 | MM14498 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 1.86e-03 | 11 | 84 | 2 | M26913 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION | 1.86e-03 | 11 | 84 | 2 | M27466 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.86e-03 | 11 | 84 | 2 | M47958 | |
| Pubmed | CYLD NRCAM SYNE1 SMC5 ZCCHC14 PLEKHG1 CRACD PER2 LGI2 BAZ2A ACOT11 OGFOD1 AGTPBP1 | 2.00e-09 | 407 | 121 | 13 | 12693553 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EPRS1 TES MAP1A RTN4 HLCS PRPF8 YWHAZ EMSY CRACD SETD2 BAZ2A CLMN AHNAK MKI67 NCOA7 PPP1R9B YWHAQ AHNAK2 | 4.28e-09 | 934 | 121 | 18 | 33916271 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | CACNA1E NRCAM MAP1A MAP6 SYNE1 YWHAH YWHAZ AHNAK DYNC1LI1 PPP1R9B AKAP11 | 4.58e-09 | 281 | 121 | 11 | 28706196 |
| Pubmed | CYLD CACNA1A CACNA1E CAD ZSCAN12 OGT NRCAM MAP6 SYNE1 MCM3 JAKMIP2 YWHAH YWHAZ EMSY NFATC3 PPP1R9B YWHAQ STOML2 | 6.86e-09 | 963 | 121 | 18 | 28671696 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CYLD MAP2 YWHAH YWHAZ ZCCHC14 PLEKHG1 RESF1 NFATC3 CLMN AHNAK CCSER2 NCOA7 AKAP11 YWHAQ MORC3 DOCK6 AHNAK2 | 8.41e-09 | 861 | 121 | 17 | 36931259 |
| Pubmed | CYLD CACNA1A EPRS1 TUT4 CAD RAE1 NRCAM MAP1A MAP2 MAP6 RTN4 PSMC1 YWHAH YWHAZ ITPR1 DYNC1LI1 PPP1R9B YWHAQ STOML2 | 1.56e-08 | 1139 | 121 | 19 | 36417873 | |
| Pubmed | EPRS1 CAD ERCC5 OGT PSMC1 MCM3 YWHAZ GSPT1 AHNAK YWHAQ DOCK6 STOML2 | 1.68e-08 | 399 | 121 | 12 | 37536630 | |
| Pubmed | CYLD CAD MAP2 NDUFAF2 SYNE1 TTLL5 RTN4 SLU7 PRPF8 ADA ITPR1 TBC1D8 PLEKHG1 BAZ2A CLMN CCSER2 TMEM65 DDX23 AKAP11 AGTPBP1 STOML2 | 4.40e-08 | 1487 | 121 | 21 | 33957083 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | EPRS1 CAD INCENP PSMC1 SLU7 MCM3 PRPF8 YWHAZ GSPT1 KIF20A PSME4 BAZ2A AHNAK MKI67 HLTF DYNC1LI1 DDX23 YWHAQ STOML2 AHNAK2 | 4.59e-08 | 1353 | 121 | 20 | 29467282 |
| Pubmed | CYLD EPC2 TUT4 TES OGT RAE1 MAP1A HLCS C11orf16 FMNL2 YWHAH ZNF518A KIF20A SETD2 RESF1 ZFHX4 BAZ2A AGTPBP1 | 6.43e-08 | 1116 | 121 | 18 | 31753913 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | HAUS7 TES OGT RAE1 INCENP SYNE1 CPS1 SMC5 PRPF8 ITPR1 KIF20A PER2 AHNAK CCSER2 MKI67 DYNC1LI1 DDX23 MORC3 | 1.07e-07 | 1155 | 121 | 18 | 20360068 |
| Pubmed | CACNA1A EPRS1 CAD OGT NRCAM MAP1A MAP2 MAP6 SYNE1 RTN4 PSMC1 FMNL2 YWHAH YWHAZ CRACD CLMN PPP1R9B YWHAQ AGTPBP1 STOML2 | 1.14e-07 | 1431 | 121 | 20 | 37142655 | |
| Pubmed | 1.85e-07 | 15 | 121 | 4 | 23572552 | ||
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | 1.94e-07 | 175 | 121 | 8 | 25756610 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | CYLD AVEN TUT4 MAP1A RTN4 SMC5 PRPF8 GSPT1 KIF20A AHNAK MKI67 PPP1R9B AGTPBP1 AHNAK2 | 2.47e-07 | 724 | 121 | 14 | 36232890 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 3.04e-07 | 256 | 121 | 9 | 33397691 | |
| Pubmed | The Cdk-like protein PCTAIRE-1 from mouse brain associates with p11 and 14-3-3 proteins. | 4.09e-07 | 5 | 121 | 3 | 9197417 | |
| Pubmed | EPRS1 RTN4 PSMC1 MCM3 PRPF8 YWHAH YWHAZ AHNAK MKI67 YWHAQ AHNAK2 HSP90AB3P | 4.22e-07 | 538 | 121 | 12 | 28524877 | |
| Pubmed | 5.10e-07 | 84 | 121 | 6 | 19165527 | ||
| Pubmed | CYLD EPRS1 OGT NRCAM JADE2 SYNE1 TTLL5 PSMC1 HLCS CMYA5 PRPF8 SEC31B FMNL2 YWHAH YWHAZ ADAMTS9 MORC3 AGTPBP1 | 5.10e-07 | 1285 | 121 | 18 | 35914814 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | CACNA1A ZSCAN12 INCENP TTLL5 FMNL2 SH3D21 ITPR1 TBC1D8 ASXL3 AHNAK EHF AKAP11 | 5.54e-07 | 552 | 121 | 12 | 10737800 |
| Pubmed | CAD JADE2 RTN4 PSMC1 MCM3 PRPF8 YWHAH YWHAZ GSPT1 ITPR1 CRACD AHNAK MKI67 HLTF DYNC1LI1 DDX23 YWHAQ STOML2 AHNAK2 | 5.86e-07 | 1440 | 121 | 19 | 30833792 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | EPRS1 TES OGT MAP2 PSMC1 MCM3 CMYA5 YWHAH YWHAZ GSPT1 TRMT6 PSME4 AHNAK DYNC1LI1 OGFOD1 PLA2G4A NCOA7 YWHAQ AHNAK2 | 6.84e-07 | 1455 | 121 | 19 | 22863883 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | EPRS1 CAD OGT RAE1 PSMC1 HLCS MCM3 PRPF8 YWHAZ EMSY GSPT1 BAZ2A AHNAK MKI67 HLTF DDX23 MORC3 STOML2 | 7.34e-07 | 1318 | 121 | 18 | 30463901 |
| Pubmed | 7.67e-07 | 144 | 121 | 7 | 35681168 | ||
| Pubmed | 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. | 8.15e-07 | 6 | 121 | 3 | 11864996 | |
| Pubmed | Specific interaction between 14-3-3 isoforms and the human CDC25B phosphatase. | 8.15e-07 | 6 | 121 | 3 | 10713667 | |
| Pubmed | The interaction between casein kinase Ialpha and 14-3-3 is phosphorylation dependent. | 8.15e-07 | 6 | 121 | 3 | 19860830 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CYLD CAD OGT RAE1 MAP1A MCM3 EMSY TBC1D8 SETD2 RESF1 NFATC3 MORC3 | 1.07e-06 | 588 | 121 | 12 | 38580884 |
| Pubmed | EPRS1 CAD OGT PSMC1 ARFGEF1 MCM3 YWHAZ KIF20A AHNAK MKI67 YWHAQ | 1.33e-06 | 494 | 121 | 11 | 26831064 | |
| Pubmed | 1.42e-06 | 7 | 121 | 3 | 10441394 | ||
| Pubmed | Interaction of apoptosis signal-regulating kinase 1 with isoforms of 14-3-3 proteins. | 1.42e-06 | 7 | 121 | 3 | 15023544 | |
| Pubmed | 1.42e-06 | 7 | 121 | 3 | 10620507 | ||
| Pubmed | 1.42e-06 | 7 | 121 | 3 | 30143532 | ||
| Pubmed | Cytosolic sequestration of spatacsin by Protein Kinase A and 14-3-3 proteins. | 1.42e-06 | 7 | 121 | 3 | 36096339 | |
| Pubmed | 1.42e-06 | 7 | 121 | 3 | 27030597 | ||
| Pubmed | The expression of seven 14-3-3 isoforms in human meningioma. | 1.42e-06 | 7 | 121 | 3 | 20388496 | |
| Pubmed | 1.42e-06 | 7 | 121 | 3 | 22588126 | ||
| Pubmed | A nonphosphorylated 14-3-3 binding motif on exoenzyme S that is functional in vivo. | 1.42e-06 | 7 | 121 | 3 | 12383250 | |
| Pubmed | 1.42e-06 | 7 | 121 | 3 | 16868027 | ||
| Pubmed | 1.42e-06 | 7 | 121 | 3 | 31906564 | ||
| Pubmed | SMARCA3, a chromatin-remodeling factor, is required for p11-dependent antidepressant action. | 1.42e-06 | 7 | 121 | 3 | 23415230 | |
| Pubmed | 1.42e-06 | 7 | 121 | 3 | 21390248 | ||
| Pubmed | 1.69e-06 | 162 | 121 | 7 | 25796446 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | CYLD HAUS7 AVEN TES TTLL5 PSMC1 HLCS MCM3 EMSY PLEKHG1 NFATC3 DYNC1LI1 YWHAQ MORC3 | 1.72e-06 | 853 | 121 | 14 | 28718761 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | EPRS1 CAD OGT RAE1 PSMC1 MCM3 PRPF8 YWHAH YWHAZ GSPT1 PSME4 HLTF DYNC1LI1 DDX23 YWHAQ USP1 STOML2 | 1.76e-06 | 1257 | 121 | 17 | 37317656 |
| Pubmed | 1.76e-06 | 163 | 121 | 7 | 16512683 | ||
| Pubmed | 2.27e-06 | 8 | 121 | 3 | 15708996 | ||
| Pubmed | Phosphorylation of human keratin 18 serine 33 regulates binding to 14-3-3 proteins. | 2.27e-06 | 8 | 121 | 3 | 9524113 | |
| Pubmed | Identification of signalling proteins interacting with B-Raf in the yeast two-hybrid system. | 2.27e-06 | 8 | 121 | 3 | 8668348 | |
| Pubmed | 2.27e-06 | 8 | 121 | 3 | 16045749 | ||
| Pubmed | Progressive degeneration of human neural stem cells caused by pathogenic LRRK2. | 2.27e-06 | 8 | 121 | 3 | 23075850 | |
| Pubmed | 2.27e-06 | 8 | 121 | 3 | 18332103 | ||
| Pubmed | 14-3-3 proteins interact with a hybrid prenyl-phosphorylation motif to inhibit G proteins. | 2.27e-06 | 8 | 121 | 3 | 23622247 | |
| Pubmed | ZSCAN12 JADE2 RTN4 TRMT6 PSME4 ABCA5 CCSER2 AKAP11 IGSF1 YWHAQ DOCK6 | 2.57e-06 | 529 | 121 | 11 | 14621295 | |
| Pubmed | A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition. | RAE1 SEC31B EMSY KIF20A ZFHX4 BAZ2A ASXL3 HLTF DDX23 SLC6A14 | 2.87e-06 | 431 | 121 | 10 | 33660365 |
| Pubmed | 2.93e-06 | 251 | 121 | 8 | 29778605 | ||
| Pubmed | MUC1 oncoprotein blocks nuclear targeting of c-Abl in the apoptotic response to DNA damage. | 3.40e-06 | 9 | 121 | 3 | 16888623 | |
| Pubmed | 14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation site(s). | 3.40e-06 | 9 | 121 | 3 | 12438239 | |
| Pubmed | Identification and characterization of the interaction between tuberin and 14-3-3zeta. | 3.40e-06 | 9 | 121 | 3 | 12176984 | |
| Pubmed | Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3. | 3.40e-06 | 9 | 121 | 3 | 16511560 | |
| Pubmed | 3.40e-06 | 9 | 121 | 3 | 18458160 | ||
| Pubmed | 14-3-3-protein regulates Nedd4-2 by modulating interactions between HECT and WW domains. | 3.40e-06 | 9 | 121 | 3 | 34294877 | |
| Pubmed | 3.40e-06 | 9 | 121 | 3 | 16581770 | ||
| Pubmed | 3.40e-06 | 9 | 121 | 3 | 12446771 | ||
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | 3.49e-06 | 344 | 121 | 9 | 36282215 | |
| Pubmed | Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation. | 3.59e-06 | 258 | 121 | 8 | 21081666 | |
| Pubmed | 3.75e-06 | 118 | 121 | 6 | 30979931 | ||
| Pubmed | 3.81e-06 | 67 | 121 | 5 | 29357390 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | TUT4 CAD INCENP NDUFAF2 SYNE1 TTLL5 RTN4 PSMC1 YWHAH YWHAZ ITPR1 TRMT6 BAZ2A CLMN AKAP11 YWHAQ STOML2 AHNAK2 | 4.36e-06 | 1496 | 121 | 18 | 32877691 |
| Pubmed | Protein phosphatase 1 binds to phospho-Ser-1394 of the macrophage-stimulating protein receptor. | 4.84e-06 | 10 | 121 | 3 | 14505491 | |
| Pubmed | 4.84e-06 | 10 | 121 | 3 | 20478393 | ||
| Pubmed | Involvement of protein kinase PKN1 in G2/M delay caused by arsenite. | 4.84e-06 | 10 | 121 | 3 | 15791647 | |
| Pubmed | 4.84e-06 | 10 | 121 | 3 | 32675284 | ||
| Pubmed | 4.84e-06 | 10 | 121 | 3 | 12433946 | ||
| Pubmed | 14-3-3 proteins play a role in the cell cycle by shielding cdt2 from ubiquitin-mediated degradation. | 4.84e-06 | 10 | 121 | 3 | 25154416 | |
| Pubmed | Functional conservation of 14-3-3 isoforms in inhibiting bad-induced apoptosis. | 4.84e-06 | 10 | 121 | 3 | 11697890 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | HAUS7 RAE1 ORC6 PSMC1 PRPF8 SEC31B GSPT1 AHNAK HLTF DYNC1LI1 DDX23 | 6.37e-06 | 582 | 121 | 11 | 20467437 |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | CAD RAE1 MCM3 PRPF8 YWHAH YWHAZ ZFHX4 NFATC3 BAZ2A HLTF YWHAQ | 6.47e-06 | 583 | 121 | 11 | 29844126 |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 6.57e-06 | 130 | 121 | 6 | 35545047 | |
| Pubmed | 6.64e-06 | 11 | 121 | 3 | 15696159 | ||
| Pubmed | EPRS1 EPC2 CAD OGT RAE1 ORC6 PSMC1 SLU7 EMSY GSPT1 RESF1 MKI67 HLTF DYNC1LI1 DDX23 | 7.05e-06 | 1103 | 121 | 15 | 34189442 | |
| Pubmed | Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. | 7.08e-06 | 283 | 121 | 8 | 18854154 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | EPRS1 CAD SYNE1 PSMC1 SLU7 MCM3 PRPF8 YWHAZ MKI67 DDX23 YWHAQ STOML2 | 7.79e-06 | 714 | 121 | 12 | 28302793 |
| Pubmed | USP1 deubiquitinates Akt to inhibit PI3K-Akt-FoxO signaling in muscle during prolonged starvation. | 8.42e-06 | 37 | 121 | 4 | 32133736 | |
| Pubmed | 8.83e-06 | 12 | 121 | 3 | 39406751 | ||
| Pubmed | 8.83e-06 | 12 | 121 | 3 | 18779327 | ||
| Pubmed | BAP1 induces cell death via interaction with 14-3-3 in neuroblastoma. | 8.83e-06 | 12 | 121 | 3 | 29686263 | |
| Pubmed | 8.83e-06 | 12 | 121 | 3 | 20642453 | ||
| Pubmed | Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein. | 8.83e-06 | 12 | 121 | 3 | 19172738 | |
| Pubmed | TUT4 TES NDUFAF2 HLCS ZCCHC14 SETD2 CUEDC2 CLMN DYNC1LI1 C6orf47 USP1 AGTPBP1 | 1.01e-05 | 733 | 121 | 12 | 34672954 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 1.04e-05 | 394 | 121 | 9 | 27248496 | |
| Pubmed | 1.15e-05 | 13 | 121 | 3 | 37228035 | ||
| Pubmed | 1.15e-05 | 13 | 121 | 3 | 22222486 | ||
| Pubmed | 1.15e-05 | 13 | 121 | 3 | 19014373 | ||
| Pubmed | 1.15e-05 | 13 | 121 | 3 | 34654719 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 35584682 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 10630211 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 15007166 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 32668300 | ||
| Interaction | KRT8 interactions | CYLD HAUS7 CAD TES OGT TTLL5 ARFGEF1 PRPF8 YWHAH YWHAZ PLEKHG1 CCSER2 PHLPP1 PPP1R9B AKAP11 YWHAQ | 7.22e-09 | 441 | 119 | 16 | int:KRT8 |
| Interaction | MAP1B interactions | CYLD CACNA1A EPRS1 CAD RAE1 MAP1A SYNE1 PSMC1 MCM3 CPS1 SMC5 PRPF8 MKI67 DDX23 PPP1R9B HSP90AB3P | 1.17e-07 | 539 | 119 | 16 | int:MAP1B |
| Interaction | JUP interactions | CYLD CAD ZSCAN12 TSHZ2 MCM3 SMC5 PRPF8 FMNL2 YWHAH YWHAZ KIF20A PHLPP1 PPP1R9B USP1 EPAS1 | 1.77e-07 | 485 | 119 | 15 | int:JUP |
| Interaction | NAV2 interactions | 1.90e-07 | 43 | 119 | 6 | int:NAV2 | |
| Interaction | PLEC interactions | CYLD TES MAP1A MAP2 PRPF8 YWHAH YWHAZ ITPR1 KIF20A PER2 AHNAK PHLPP1 PPP1R9B YWHAQ | 2.53e-07 | 430 | 119 | 14 | int:PLEC |
| Interaction | KIF23 interactions | EPRS1 INCENP PSMC1 MCM3 CPS1 SMC5 PRPF8 YWHAH YWHAZ KIF20A PER2 AHNAK MKI67 PHLPP1 DDX23 PPP1R9B YWHAQ EPAS1 STOML2 AHNAK2 HSP90AB3P | 6.10e-07 | 1031 | 119 | 21 | int:KIF23 |
| Interaction | S100A10 interactions | 6.41e-07 | 122 | 119 | 8 | int:S100A10 | |
| Interaction | PHLPP1 interactions | EPRS1 RTN4 CMYA5 NEB PRPF8 KIF20A AHNAK PHLPP1 PLA2G4A USP1 AGTPBP1 AHNAK2 | 6.64e-07 | 333 | 119 | 12 | int:PHLPP1 |
| Interaction | SHANK3 interactions | CYLD NRCAM MAP1A MAP2 MAP6 SYNE1 RTN4 YWHAZ DPH6 ITPR1 SETD2 PPP1R9B YWHAQ STOML2 | 1.39e-06 | 496 | 119 | 14 | int:SHANK3 |
| Interaction | PCM1 interactions | CYLD HAUS7 RAE1 TTLL5 SMC5 YWHAH YWHAZ KIF20A PLEKHG1 PHLPP1 DDX23 PPP1R9B YWHAQ | 1.77e-06 | 434 | 119 | 13 | int:PCM1 |
| Interaction | SMTNL2 interactions | 1.86e-06 | 35 | 119 | 5 | int:SMTNL2 | |
| Interaction | DLD interactions | EPRS1 OGT PSMC1 MCM3 YWHAH YWHAZ HLTF DYNC1LI1 PHLPP1 DDX23 PPP1R9B YWHAQ USP1 STOML2 | 2.76e-06 | 526 | 119 | 14 | int:DLD |
| Interaction | CAPZB interactions | CYLD EPRS1 CAD TES PSMC1 YWHAH YWHAZ GSPT1 ITPR1 KIF20A CRACD TRMT6 PER2 BAZ2A MKI67 DYNC1LI1 PPP1R9B YWHAQ AGTPBP1 STOML2 | 3.22e-06 | 1049 | 119 | 20 | int:CAPZB |
| Interaction | HECTD4 interactions | 3.68e-06 | 40 | 119 | 5 | int:HECTD4 | |
| Interaction | NAA40 interactions | EPRS1 TES MAP1A RTN4 HLCS SMC5 PRPF8 YWHAZ EMSY CRACD SETD2 BAZ2A CLMN AHNAK MKI67 NCOA7 PPP1R9B YWHAQ AHNAK2 | 4.47e-06 | 978 | 119 | 19 | int:NAA40 |
| Interaction | HSPA9 interactions | CYLD EPRS1 OGT HEATR4 PSMC1 CPS1 PRPF8 YWHAZ ITPR1 CUEDC2 ASXL3 AHNAK DDX23 PPP1R9B USP1 STOML2 | 5.90e-06 | 727 | 119 | 16 | int:HSPA9 |
| Interaction | YWHAH interactions | CYLD OGT RAE1 MAP2 YWHAH YWHAZ ZCCHC14 PLEKHG1 RESF1 NFATC3 CLMN AHNAK CCSER2 NCOA7 PPP1R9B AKAP11 YWHAQ MORC3 DOCK6 AHNAK2 | 6.73e-06 | 1102 | 119 | 20 | int:YWHAH |
| Interaction | ANXA2 interactions | CYLD SMC5 PRPF8 YWHAZ KIF20A AHNAK HLTF DYNC1LI1 PLA2G4A PPP1R9B YWHAQ AHNAK2 | 7.12e-06 | 419 | 119 | 12 | int:ANXA2 |
| Interaction | PAXBP1 interactions | 7.59e-06 | 121 | 119 | 7 | int:PAXBP1 | |
| Interaction | ATAT1 interactions | 7.79e-06 | 22 | 119 | 4 | int:ATAT1 | |
| Interaction | TJP2 interactions | RAE1 MCM3 YWHAH YWHAZ KIF20A CRACD CUEDC2 DDX23 PPP1R9B YWHAQ | 8.21e-06 | 288 | 119 | 10 | int:TJP2 |
| Interaction | YWHAZ interactions | CYLD CAD OGT RAE1 MAP2 MAP6 NEB SMC5 PRPF8 YWHAH YWHAZ ITPR1 CRACD PER2 NFATC3 ASXL3 CCSER2 DYNC1LI1 PPP1R9B AKAP11 YWHAQ MORC3 | 8.41e-06 | 1319 | 119 | 22 | int:YWHAZ |
| Interaction | KSR2 interactions | 9.22e-06 | 48 | 119 | 5 | int:KSR2 | |
| Interaction | CCSER1 interactions | 9.38e-06 | 23 | 119 | 4 | int:CCSER1 | |
| Interaction | DIDO1 interactions | 9.92e-06 | 176 | 119 | 8 | int:DIDO1 | |
| Interaction | MOB3C interactions | EPRS1 CAD ERCC5 OGT PSMC1 MCM3 YWHAZ GSPT1 AHNAK YWHAQ DOCK6 | 1.06e-05 | 364 | 119 | 11 | int:MOB3C |
| Interaction | HNRNPA1 interactions | CYLD EPRS1 CAD OGT SLU7 NEB SMC5 PRPF8 ADA YWHAZ GSPT1 KIF20A IVL PER2 ASXL3 MKI67 DDX23 YWHAQ | 1.08e-05 | 945 | 119 | 18 | int:HNRNPA1 |
| Interaction | SH3PXD2A interactions | 1.10e-05 | 128 | 119 | 7 | int:SH3PXD2A | |
| Interaction | KCNK15 interactions | 1.10e-05 | 8 | 119 | 3 | int:KCNK15 | |
| Interaction | BRCA1 interactions | EPRS1 AVEN CAD ERCC5 OGT PSMC1 ARFGEF1 MCM3 USP37 SMC5 YWHAZ EMSY ITPR1 KIF20A AHNAK MKI67 HLTF DDX23 PPP1R9B YWHAQ MORC3 | 1.23e-05 | 1249 | 119 | 21 | int:BRCA1 |
| Interaction | CHMP4C interactions | EPRS1 CAD RAE1 INCENP SLU7 MCM3 CPS1 PRPF8 YWHAZ AHNAK MKI67 DDX23 YWHAQ STOML2 HSP90AB3P | 1.30e-05 | 687 | 119 | 15 | int:CHMP4C |
| Interaction | LNP1 interactions | 1.33e-05 | 25 | 119 | 4 | int:LNP1 | |
| Interaction | HSP90AB1 interactions | CYLD TES OGT CPS1 NEB SMC5 PRPF8 YWHAH YWHAZ KIF20A UNC45B ASXL3 AHNAK PLA2G4A PPP1R9B YWHAQ STOML2 HSP90AB3P | 1.33e-05 | 960 | 119 | 18 | int:HSP90AB1 |
| Interaction | USP43 interactions | 1.37e-05 | 52 | 119 | 5 | int:USP43 | |
| Interaction | SFN interactions | CYLD RAE1 MAP1A MAP2 NEB PRPF8 YWHAH YWHAZ IVL NFATC3 CLMN CCSER2 AKAP11 YWHAQ AHNAK2 | 1.41e-05 | 692 | 119 | 15 | int:SFN |
| Interaction | KCNK9 interactions | 1.64e-05 | 9 | 119 | 3 | int:KCNK9 | |
| Interaction | ENO1 interactions | CYLD OGT MAP6 NEB SMC5 PRPF8 YWHAZ PER2 NFATC3 ASXL3 AHNAK NCOA7 PPP1R9B YWHAQ AGTPBP1 | 1.64e-05 | 701 | 119 | 15 | int:ENO1 |
| Interaction | VIM interactions | CYLD CAD TES OGT NEB SMC5 PRPF8 YWHAH YWHAZ KIF20A PLEKHG1 RESF1 CCSER2 PLA2G4A PPP1R9B YWHAQ | 2.05e-05 | 804 | 119 | 16 | int:VIM |
| Interaction | DOCK11 interactions | 2.16e-05 | 57 | 119 | 5 | int:DOCK11 | |
| Interaction | NUAK1 interactions | 2.24e-05 | 96 | 119 | 6 | int:NUAK1 | |
| Interaction | CCT8 interactions | CYLD EPRS1 CAD OGT SYNE1 SMC5 PRPF8 SEC31B GSPT1 PER2 ASXL3 PHLPP1 PPP1R9B | 2.25e-05 | 550 | 119 | 13 | int:CCT8 |
| Interaction | OTOG interactions | 2.34e-05 | 10 | 119 | 3 | int:OTOG | |
| Interaction | DYRK1A interactions | CYLD TES ERCC5 OGT YWHAH KIF20A ADAMTS9 AHNAK MKI67 AKAP11 YWHAQ DOCK6 AHNAK2 | 2.34e-05 | 552 | 119 | 13 | int:DYRK1A |
| Interaction | PPP1R12C interactions | 2.35e-05 | 58 | 119 | 5 | int:PPP1R12C | |
| Interaction | SPEG interactions | 2.45e-05 | 29 | 119 | 4 | int:SPEG | |
| Interaction | PPHLN1 interactions | 2.58e-05 | 146 | 119 | 7 | int:PPHLN1 | |
| Interaction | BAIAP2 interactions | 2.59e-05 | 201 | 119 | 8 | int:BAIAP2 | |
| Interaction | HIVEP2 interactions | 2.81e-05 | 30 | 119 | 4 | int:HIVEP2 | |
| Interaction | TICRR interactions | 2.81e-05 | 30 | 119 | 4 | int:TICRR | |
| Interaction | CDCA7 interactions | 3.20e-05 | 11 | 119 | 3 | int:CDCA7 | |
| Interaction | MACIR interactions | 3.21e-05 | 31 | 119 | 4 | int:MACIR | |
| Interaction | RACGAP1 interactions | 3.31e-05 | 208 | 119 | 8 | int:RACGAP1 | |
| Interaction | SRSF10 interactions | 3.36e-05 | 271 | 119 | 9 | int:SRSF10 | |
| Interaction | SNW1 interactions | OGT RAE1 ORC6 PSMC1 SLU7 SMC5 PRPF8 SEC31B GSPT1 TRMT6 AHNAK MKI67 HLTF PHLPP1 DDX23 | 3.43e-05 | 747 | 119 | 15 | int:SNW1 |
| Interaction | PPP5C interactions | 3.45e-05 | 272 | 119 | 9 | int:PPP5C | |
| Interaction | MAP2 interactions | 3.54e-05 | 104 | 119 | 6 | int:MAP2 | |
| Interaction | AGAP2 interactions | 3.55e-05 | 210 | 119 | 8 | int:AGAP2 | |
| Interaction | USP46 interactions | 3.81e-05 | 64 | 119 | 5 | int:USP46 | |
| Interaction | DCTN1 interactions | CYLD HAUS7 TES MAP1A MAP2 MCM3 YWHAH YWHAZ KIF20A CCSER2 DYNC1LI1 PPP1R9B | 3.85e-05 | 497 | 119 | 12 | int:DCTN1 |
| Interaction | SLU7 interactions | 3.95e-05 | 156 | 119 | 7 | int:SLU7 | |
| Interaction | SH3BP5L interactions | 4.14e-05 | 33 | 119 | 4 | int:SH3BP5L | |
| Interaction | DSP interactions | CYLD EPRS1 ZSCAN12 SMC5 PRPF8 YWHAH KIF20A IVL AHNAK PHLPP1 PPP1R9B | 4.23e-05 | 423 | 119 | 11 | int:DSP |
| Interaction | PPP1R3E interactions | 4.25e-05 | 12 | 119 | 3 | int:PPP1R3E | |
| Interaction | REM1 interactions | 4.25e-05 | 12 | 119 | 3 | int:REM1 | |
| Interaction | CDC5L interactions | CYLD HAUS7 ERCC5 OGT ORC6 SYNE1 PSMC1 MCM3 SMC5 PRPF8 YWHAZ AHNAK HLTF DYNC1LI1 DDX23 YWHAQ | 4.31e-05 | 855 | 119 | 16 | int:CDC5L |
| Interaction | TAB3 interactions | 4.42e-05 | 66 | 119 | 5 | int:TAB3 | |
| Interaction | EML3 interactions | 4.42e-05 | 66 | 119 | 5 | int:EML3 | |
| Interaction | LIMA1 interactions | TES PSMC1 PRPF8 YWHAH YWHAZ KIF20A AHNAK MKI67 PHLPP1 PPP1R9B YWHAQ | 4.80e-05 | 429 | 119 | 11 | int:LIMA1 |
| Interaction | CRY1 interactions | 5.02e-05 | 162 | 119 | 7 | int:CRY1 | |
| Interaction | ABI1 interactions | 5.42e-05 | 223 | 119 | 8 | int:ABI1 | |
| Interaction | KCNK3 interactions | 5.50e-05 | 13 | 119 | 3 | int:KCNK3 | |
| Interaction | PPP1CA interactions | CAD TES OGT MCM3 PRPF8 YWHAH YWHAZ GSPT1 KIF20A CUEDC2 MKI67 PPP1R9B AKAP11 YWHAQ | 6.27e-05 | 696 | 119 | 14 | int:PPP1CA |
| Interaction | H2BC21 interactions | CACNA1E EPRS1 EPC2 INCENP SLU7 MCM3 NEB PRPF8 FMNL2 KIF20A AHNAK MKI67 HLTF AKAP11 | 6.27e-05 | 696 | 119 | 14 | int:H2BC21 |
| Interaction | SEPTIN7 interactions | 6.34e-05 | 228 | 119 | 8 | int:SEPTIN7 | |
| Interaction | HSPH1 interactions | CYLD CAD PSMC1 ARFGEF1 MCM3 CPS1 YWHAH GSPT1 PHLPP1 PPP1R9B YWHAQ | 7.08e-05 | 448 | 119 | 11 | int:HSPH1 |
| Interaction | H2AZ1 interactions | EPC2 INCENP USP37 SMC5 EMSY KIF20A BAZ2A OGFOD1 DDX23 AKAP11 | 7.11e-05 | 371 | 119 | 10 | int:H2AZ1 |
| Interaction | PAK6 interactions | 7.19e-05 | 73 | 119 | 5 | int:PAK6 | |
| Interaction | CMYA5 interactions | 7.30e-05 | 38 | 119 | 4 | int:CMYA5 | |
| Interaction | ARAF interactions | 7.95e-05 | 376 | 119 | 10 | int:ARAF | |
| Interaction | TMCC3 interactions | 8.10e-05 | 39 | 119 | 4 | int:TMCC3 | |
| Interaction | DUSP16 interactions | 8.31e-05 | 237 | 119 | 8 | int:DUSP16 | |
| Interaction | NUP43 interactions | ERCC5 RAE1 INCENP CCDC168 EMSY ZNF518A SETD2 RESF1 BAZ2A CCSER2 MKI67 HLTF AHNAK2 | 8.33e-05 | 625 | 119 | 13 | int:NUP43 |
| Interaction | SLC8A2 interactions | 8.67e-05 | 15 | 119 | 3 | int:SLC8A2 | |
| Interaction | PABIR2 interactions | 8.96e-05 | 40 | 119 | 4 | int:PABIR2 | |
| Interaction | CTNNB1 interactions | CYLD CAD TES RAE1 RTN4 ARFGEF1 USP37 FMNL2 YWHAZ KIF20A ABCA5 CLMN MKI67 PPP1R9B YWHAQ SLAMF7 EPAS1 | 8.97e-05 | 1009 | 119 | 17 | int:CTNNB1 |
| Interaction | LARP1 interactions | CYLD OGT MCM3 SMC5 YWHAH YWHAZ GSPT1 KIF20A DYNC1LI1 PHLPP1 YWHAQ | 9.86e-05 | 465 | 119 | 11 | int:LARP1 |
| Interaction | WDR37 interactions | 9.87e-05 | 78 | 119 | 5 | int:WDR37 | |
| Interaction | SIPA1 interactions | 9.89e-05 | 41 | 119 | 4 | int:SIPA1 | |
| Interaction | YTHDF2 interactions | 9.92e-05 | 312 | 119 | 9 | int:YTHDF2 | |
| Interaction | TERF2IP interactions | ERCC5 OGT INCENP SLU7 ADA EMSY SETD2 TRMT6 BAZ2A MKI67 DDX23 EPAS1 | 1.05e-04 | 552 | 119 | 12 | int:TERF2IP |
| Interaction | PPP1CB interactions | CAD TES OGT PSMC1 MCM3 USP37 GSPT1 KIF20A DYNC1LI1 PPP1R9B AKAP11 | 1.06e-04 | 469 | 119 | 11 | int:PPP1CB |
| Interaction | SAMSN1 interactions | 1.06e-04 | 16 | 119 | 3 | int:SAMSN1 | |
| Interaction | TESPA1 interactions | 1.06e-04 | 16 | 119 | 3 | int:TESPA1 | |
| Interaction | DZIP1 interactions | 1.09e-04 | 42 | 119 | 4 | int:DZIP1 | |
| Interaction | TUBB interactions | CYLD EPRS1 CAD TES OGT MAP1A MAP6 SMC5 PRPF8 YWHAZ ASXL3 DDX23 PPP1R9B YWHAQ | 1.12e-04 | 735 | 119 | 14 | int:TUBB |
| Interaction | OGA interactions | 1.18e-04 | 129 | 119 | 6 | int:OGA | |
| Interaction | SYDE2 interactions | 1.19e-04 | 43 | 119 | 4 | int:SYDE2 | |
| Interaction | SSH2 interactions | 1.19e-04 | 43 | 119 | 4 | int:SSH2 | |
| Interaction | FLNA interactions | CYLD EPRS1 TES SMC5 PRPF8 KIF20A CRACD PER2 AHNAK DYNC1LI1 PHLPP1 PPP1R9B YWHAQ | 1.20e-04 | 648 | 119 | 13 | int:FLNA |
| Interaction | RUFY1 interactions | EPRS1 CAD PSMC1 MCM3 FMNL2 YWHAZ PSME4 DYNC1LI1 YWHAQ STOML2 HSP90AB3P | 1.21e-04 | 476 | 119 | 11 | int:RUFY1 |
| GeneFamily | 14-3-3 phospho-serine/phospho-threonine binding proteins | 2.28e-06 | 7 | 74 | 3 | 1053 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 2.23e-04 | 29 | 74 | 3 | 396 | |
| GeneFamily | Ubiquitin specific peptidases | 1.56e-03 | 56 | 74 | 3 | 366 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.68e-03 | 15 | 74 | 2 | 529 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | EPRS1 NRCAM MAP1A MAP2 MAP6 RTN4 PRPF8 ZCCHC14 CRACD ABCA5 EDARADD CCSER2 TMEM65 HLTF AKAP11 IGSF1 USP1 AGTPBP1 | 3.12e-07 | 946 | 120 | 18 | M39169 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CYLD CACNA1A CACNA1E TUT4 TES MAP2 MAP6 TSHZ2 RTN4 ARFGEF1 NEB SEC31B FMNL2 ZFHX4 LGI2 ASXL3 NCOA7 AGTPBP1 AHNAK2 | 6.67e-07 | 1106 | 120 | 19 | M39071 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | EPRS1 TUT4 ERCC5 ARFGEF1 SLU7 JAKMIP2 ITPR1 RESF1 ABCA5 MKI67 HLTF AKAP11 USP1 AGTPBP1 | 1.92e-06 | 656 | 120 | 14 | M18979 |
| Coexpression | BLUM_RESPONSE_TO_SALIRASIB_DN | 3.99e-06 | 341 | 120 | 10 | M2879 | |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | 4.36e-06 | 426 | 120 | 11 | M9516 | |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | 1.17e-05 | 166 | 120 | 7 | M39026 | |
| Coexpression | JISON_SICKLE_CELL_DISEASE_DN | 2.45e-05 | 186 | 120 | 7 | M4911 | |
| Coexpression | GSE369_IFNG_KO_VS_WT_LIVER_UP | 3.77e-05 | 199 | 120 | 7 | M5970 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_DN | 3.77e-05 | 199 | 120 | 7 | M4984 | |
| Coexpression | HU_FETAL_RETINA_RGC | NRCAM MAP2 MAP6 RTN4 JAKMIP2 YWHAH YWHAZ DYNC1LI1 YWHAQ PHYHIPL | 3.81e-05 | 443 | 120 | 10 | M39269 |
| Coexpression | GSE18893_TCONV_VS_TREG_2H_CULTURE_UP | 3.90e-05 | 200 | 120 | 7 | M7301 | |
| Coexpression | GSE40273_GATA1_KO_VS_WT_TREG_UP | 3.90e-05 | 200 | 120 | 7 | M9132 | |
| Coexpression | GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_UP | 3.90e-05 | 200 | 120 | 7 | M5680 | |
| Coexpression | FEVR_CTNNB1_TARGETS_DN | INCENP ORC6 MCM3 ADA YWHAZ KIF20A TRMT6 EHF MKI67 PLA2G4A USP1 | 5.04e-05 | 555 | 120 | 11 | M2343 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | NRCAM INCENP ORC6 MCM3 USP37 SMC5 JAKMIP2 KIF20A TRMT6 MKI67 YWHAQ PHYHIPL | 6.93e-05 | 680 | 120 | 12 | MM456 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 7.44e-05 | 300 | 120 | 8 | M8702 | |
| Coexpression | FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP | 7.85e-05 | 154 | 120 | 6 | M19681 | |
| Coexpression | KONG_E2F3_TARGETS | 8.52e-05 | 97 | 120 | 5 | MM1105 | |
| Coexpression | CHIARETTI_T_ALL_RELAPSE_PROGNOSIS | 8.60e-05 | 19 | 120 | 3 | M17204 | |
| Coexpression | SCHLOSSER_SERUM_RESPONSE_DN | ZSCAN12 OGT RTN4 ARFGEF1 SMC5 YWHAZ BAZ2A HLTF PHLPP1 PLA2G4A YWHAQ MORC3 | 9.74e-05 | 705 | 120 | 12 | M1410 |
| Coexpression | KONG_E2F3_TARGETS | 9.84e-05 | 100 | 120 | 5 | M1157 | |
| Coexpression | BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP | 1.03e-04 | 53 | 120 | 4 | M4448 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | ORC6 SMC5 ZCCHC14 SETD2 PRDM10 RESF1 PER2 BAZ2A CCSER2 DYNC1LI1 PLA2G4A MORC3 AHNAK2 | 1.03e-04 | 822 | 120 | 13 | M6782 |
| Coexpression | BURTON_ADIPOGENESIS_3 | 1.03e-04 | 101 | 120 | 5 | M1577 | |
| Coexpression | SESTO_RESPONSE_TO_UV_C2 | 1.11e-04 | 54 | 120 | 4 | M2589 | |
| Coexpression | BURTON_ADIPOGENESIS_3 | 1.18e-04 | 104 | 120 | 5 | MM1180 | |
| Coexpression | DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN | 1.24e-04 | 323 | 120 | 8 | M12570 | |
| Coexpression | LE_EGR2_TARGETS_UP | 1.48e-04 | 109 | 120 | 5 | MM1148 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CYLD TUT4 OGT JADE2 SYNE1 SMC5 PRPF8 YWHAZ ITPR1 SETD2 RESF1 NFATC3 AHNAK CCSER2 AKAP11 YWHAQ SLAMF7 USP1 | 1.52e-04 | 1492 | 120 | 18 | M40023 |
| Coexpression | LE_EGR2_TARGETS_UP | 1.54e-04 | 110 | 120 | 5 | M12804 | |
| Coexpression | IBRAHIM_NRF2_UP | AVEN NRCAM MAP1A MAP2 RTN4 PSMC1 ARFGEF1 SLU7 DYNC1LI1 NCOA7 | 1.75e-04 | 533 | 120 | 10 | M42510 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.84e-04 | 180 | 120 | 6 | M8239 | |
| Coexpression | KONDO_COLON_CANCER_HCP_WITH_H3K27ME1 | 2.25e-04 | 26 | 120 | 3 | M13354 | |
| Coexpression | DEN_INTERACT_WITH_LCA5 | 2.25e-04 | 26 | 120 | 3 | M1380 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | 2.96e-04 | 465 | 120 | 9 | M39066 | |
| Coexpression | GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_UP | 3.00e-04 | 197 | 120 | 6 | M7977 | |
| Coexpression | GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_DN | 3.17e-04 | 199 | 120 | 6 | M9418 | |
| Coexpression | GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP | 3.17e-04 | 199 | 120 | 6 | M7596 | |
| Coexpression | GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP | 3.17e-04 | 199 | 120 | 6 | M9330 | |
| Coexpression | GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN | 3.17e-04 | 199 | 120 | 6 | M7607 | |
| Coexpression | GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_UP | 3.25e-04 | 200 | 120 | 6 | M4601 | |
| Coexpression | GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_UP | 3.25e-04 | 200 | 120 | 6 | M8087 | |
| Coexpression | FISCHER_G1_S_CELL_CYCLE | 3.25e-04 | 200 | 120 | 6 | M107 | |
| Coexpression | GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP | 3.25e-04 | 200 | 120 | 6 | M3277 | |
| Coexpression | GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_DN | 3.25e-04 | 200 | 120 | 6 | M4538 | |
| Coexpression | GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_KO_MACROPHAGE_DN | 3.25e-04 | 200 | 120 | 6 | M9037 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_UP | 3.25e-04 | 200 | 120 | 6 | M4488 | |
| Coexpression | GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_DN | 3.25e-04 | 200 | 120 | 6 | M4314 | |
| Coexpression | GUILLAUMOND_KLF10_TARGETS_DN | 3.47e-04 | 30 | 120 | 3 | M2486 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | CYLD TUT4 INCENP TSHZ2 SYNE1 USP37 ADA BMP3 ZFHX4 ACOT11 ASXL3 EDARADD EHF MKI67 PLA2G4A USP1 EPAS1 | 4.58e-06 | 834 | 120 | 17 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | CACNA1A EPC2 TUT4 TES ZSCAN12 MAP2 ORC6 SMC5 ADA EMSY GSPT1 ZNF518A DPH6 CRACD TRMT6 RESF1 PSME4 MKI67 YWHAQ USP1 | 2.30e-05 | 1252 | 120 | 20 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | EPC2 TUT4 SYNE1 ARFGEF1 SMC5 ADA ZFHX4 ACOT11 EHF MKI67 YWHAQ | 3.46e-05 | 432 | 120 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | EPC2 TUT4 ZSCAN12 ERCC5 NRCAM INCENP MAP2 MAP6 ORC6 SMC5 ADA FMNL2 EMSY GSPT1 CRACD TRMT6 PSME4 MKI67 YWHAQ USP1 PHYHIPL | 6.44e-05 | 1459 | 120 | 21 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | EPC2 TUT4 ZSCAN12 ERCC5 NRCAM INCENP ORC6 SMC5 ADA FMNL2 EMSY GSPT1 CRACD TRMT6 PSME4 MKI67 YWHAQ USP1 PHYHIPL | 7.93e-05 | 1257 | 120 | 19 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | NRCAM MAP1A MAP2 SMC5 ADA JAKMIP2 PHLPP1 IGSF1 USP1 PHYHIPL HSP90AB3P | 1.13e-04 | 493 | 120 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | CACNA1A EPRS1 TUT4 NRCAM MAP1A MAP2 SMC5 JAKMIP2 ZNF518A CRACD SETD2 TRMT6 MKI67 PHLPP1 PHYHIPL HSP90AB3P | 1.43e-04 | 989 | 120 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | EPC2 TUT4 MAP2 SYNE1 ARFGEF1 SMC5 ADA JAKMIP2 TRMT6 ZFHX4 ACOT11 EHF TMEM65 MKI67 YWHAQ HSP90AB3P | 1.43e-04 | 989 | 120 | 16 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | HAUS7 TUT4 MAP2 ARFGEF1 FMNL2 SH3D21 ITPR1 RESF1 ZFHX4 ADAMTS9 AHNAK PLA2G4A NCOA7 MORC3 | 1.53e-04 | 791 | 120 | 14 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000 |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-07 | 176 | 121 | 7 | 74f851a398c7562dd713bc0d8d488c0037243112 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-07 | 176 | 121 | 7 | 31b5459a978d5cdde0af03a77401e0464d8c95ba | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 7.82e-07 | 186 | 121 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.67e-07 | 192 | 121 | 7 | 1d0d6fb89a2b941b7caab2f1f07d6bd5433a11e7 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.07e-06 | 195 | 121 | 7 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD8+_Memory_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.11e-06 | 196 | 121 | 7 | af00c31612e4fe068e5fccae05368edba46bbd20 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.15e-06 | 197 | 121 | 7 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-06 | 197 | 121 | 7 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-06 | 197 | 121 | 7 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-06 | 197 | 121 | 7 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-06 | 197 | 121 | 7 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.87e-06 | 159 | 121 | 6 | bf8ff9251bcb64b2b9d6dd93461aec97659686ec | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.02e-06 | 165 | 121 | 6 | e2aebb2fe197151e019371b8960f76f0c2386f08 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.02e-06 | 165 | 121 | 6 | b087771499aeb31cc4a338d2d0a9392a4ec1ac45 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.02e-06 | 165 | 121 | 6 | d8f8b088fd28a6b9dbd6b51bcaee42000e963321 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.16e-06 | 174 | 121 | 6 | ff13a5c55d18b951315908f33cb47c7f9cb901bf | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.16e-06 | 174 | 121 | 6 | 66555c610251ea04f968c258e312d720c18e7cde | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.43e-06 | 175 | 121 | 6 | cc596907ea1a64ab7b5a8c7d4ad12e6ee59bfed9 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.43e-06 | 175 | 121 | 6 | a8400e7e47379901dcab5f2e364c3ff17765b4b9 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.43e-06 | 175 | 121 | 6 | 8a3abf40146ae3459d97cdf865c1c8f6b92ac639 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.43e-06 | 175 | 121 | 6 | 378d2b79edac91fc74eee0fb42bb29dd9b07c36f | |
| ToppCell | COVID-19-kidney-Stressed_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.59e-06 | 179 | 121 | 6 | 754f69bac7a1d5137f5141f6193285ccbfe361cb | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-06 | 180 | 121 | 6 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-06 | 180 | 121 | 6 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-06 | 180 | 121 | 6 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-05 | 183 | 121 | 6 | 2f0ee40e69ad1259e56e8ee4b352736900eb8901 | |
| ToppCell | normal-na-Lymphocytic-lymphocyte-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.12e-05 | 184 | 121 | 6 | 2c286712428662bc4589dc5ac4011bf7ed403cb5 | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-05 | 185 | 121 | 6 | fa94c4a1660967f211ba095606cd0aa37d38e17a | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.16e-05 | 185 | 121 | 6 | 673308ca0514a4d3629d61fe91e9d8fb31b72166 | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.23e-05 | 187 | 121 | 6 | 37d8ee5c8bd6324749e5a2adef1d0482c75da80c | |
| ToppCell | 3'-Adult-Appendix-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.23e-05 | 187 | 121 | 6 | ec98d5e480b08854dfd0ba6b1dc6610455f90640 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 187 | 121 | 6 | 14c239af77116d28d511dea754b6150d20488080 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-05 | 187 | 121 | 6 | 9225caf66e06ebe57e90d677122acb6498607f36 | |
| ToppCell | Control-B_intermediate-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.31e-05 | 189 | 121 | 6 | 11cb9a16f1de8f60af2073ed7ea6d4f41c02f299 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 189 | 121 | 6 | 258ef4a52f90236dbed92f325ca033c8fa6156a5 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.39e-05 | 191 | 121 | 6 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.43e-05 | 192 | 121 | 6 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 1.43e-05 | 192 | 121 | 6 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | control-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.47e-05 | 193 | 121 | 6 | 89d407a88b5956559a589425b89b3eb8dc78e1dd | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 193 | 121 | 6 | 6995ee29bf403a71247de92a37dfd851be5acf2e | |
| ToppCell | P07-Endothelial-proliferative_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.47e-05 | 193 | 121 | 6 | 1e95ef29357969ee385b4717c0b5a497390ac260 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.47e-05 | 193 | 121 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.47e-05 | 193 | 121 | 6 | c0973a2c97deb7176c2f617c8760a55f7edc9839 | |
| ToppCell | P07-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.47e-05 | 193 | 121 | 6 | 0f21fb8b35f89f4c1c8109d1a4d3d08a452f9edd | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.47e-05 | 193 | 121 | 6 | 479abb1cd2eb978b8a4fdb900069a6329fc8cade | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 193 | 121 | 6 | 7fcfb0f76789fa8d8caa18304cb43c8fd899a81b | |
| ToppCell | P03-Endothelial-proliferative_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.51e-05 | 194 | 121 | 6 | 22bcfb0f3f73608feb22c0847ab4d34f87aeede0 | |
| ToppCell | P03-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.51e-05 | 194 | 121 | 6 | 5e56ce9b9fe0721be3a9e6efe1422599bb867721 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Pro-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.51e-05 | 194 | 121 | 6 | 3590ff471f74a361ee5bf02a58e3104cd3bf7d00 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-05 | 195 | 121 | 6 | 7ae732f100e9a3c6062be5b877efa1ec9d5b3958 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.56e-05 | 195 | 121 | 6 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-05 | 195 | 121 | 6 | 043e2f19d95e94cd5219e2c415f322ed340aa80f | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-05 | 196 | 121 | 6 | 5ddd314d3def3776dc7da83778d41c6436ca51ac | |
| ToppCell | myeloid-pro-pDC|myeloid / Lineage and Cell class | 1.61e-05 | 196 | 121 | 6 | 70daf4fabb68aecc5cc9f03d6f6495dd29b74a16 | |
| ToppCell | Thalamus|World / BrainAtlas - Mouse McCarroll V32 | 1.64e-05 | 116 | 121 | 5 | 5ddfb2dd5459ff6d7ae38163a38eae64fda283b7 | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.65e-05 | 197 | 121 | 6 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | facs-Brain_Non-Myeloid|facs / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 197 | 121 | 6 | a1f7eec1aca03432caa8fe817ff6d24b29d4062d | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.65e-05 | 197 | 121 | 6 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | myeloid-pro-pDC|World / Lineage and Cell class | 1.65e-05 | 197 | 121 | 6 | 8918ee006b16f6b86ed33ce1dd5c0f01f51f88f5 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 197 | 121 | 6 | f84f0ddf51208764ab56408d97035bbff562e59d | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 197 | 121 | 6 | a0d463825b62de49466f9fa563405dda4387cfff | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-05 | 198 | 121 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | severe-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.70e-05 | 198 | 121 | 6 | 4d8591eabb543ed789f963b507a07c560c76a7c9 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.70e-05 | 198 | 121 | 6 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-05 | 198 | 121 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Bronchial_Biopsy|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.70e-05 | 198 | 121 | 6 | f5b7013045b61fc56894f80092f799770dde1c8f | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.70e-05 | 198 | 121 | 6 | cd876fba12ff30b74aa507286cb1f3a867011a92 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Airway-Club|Control_saline / Treatment groups by lineage, cell group, cell type | 1.75e-05 | 199 | 121 | 6 | 5cc8b553a58669a30eb10845beb23983dcdf5a6a | |
| ToppCell | healthy_donor-Lymphocytic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.75e-05 | 199 | 121 | 6 | 2841e16d54acd344ba454f024e285c28abc37319 | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.80e-05 | 200 | 121 | 6 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.80e-05 | 200 | 121 | 6 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-05 | 200 | 121 | 6 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | 356C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.80e-05 | 200 | 121 | 6 | 97e47eb69d1d4cab45256acca9589837eb7817e7 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.80e-05 | 200 | 121 | 6 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| ToppCell | myeloid-pro-cDC|myeloid / Lineage and Cell class | 1.80e-05 | 200 | 121 | 6 | 4aa2308eeb94e0bdff4e02eb9e45ba8837ae14bf | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 1.80e-05 | 200 | 121 | 6 | 9c2095dcf70f1288d55d0ff4a97efd4fd8d0c9ee | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Highly_activated_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.80e-05 | 200 | 121 | 6 | d92d3bc63a56a604d7b1d49e62d4304e5e4017f2 | |
| ToppCell | ILEUM-inflamed-(1)_Highly_activated_T_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.80e-05 | 200 | 121 | 6 | 6ff811fdfe49b5b0aea0e88fae80bfaaf40eb7c4 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-T/NK_proliferative|IIF / Disease, condition lineage and cell class | 1.80e-05 | 200 | 121 | 6 | c7c1806a1054b2b034a26a18aac93fc3bec4dbc8 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-05 | 200 | 121 | 6 | 8827653738a931e4a4545e0c7d75be12bed40740 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.80e-05 | 200 | 121 | 6 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | mild-CD8+_Tem|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.80e-05 | 200 | 121 | 6 | a7870c5728b2c17d1d0e4fe728599f186966861b | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.80e-05 | 200 | 121 | 6 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.80e-05 | 200 | 121 | 6 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.93e-05 | 146 | 121 | 5 | 2d907e50206c4762a8baa741363bc7f0a04bd84e | |
| ToppCell | Adult-Immune-mast_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.55e-05 | 155 | 121 | 5 | 7c9de0591d1bf756b8e268b278bbe10bd5415dcd | |
| ToppCell | Adult-Immune-mast_cell|Adult / Lineage, Cell type, age group and donor | 7.84e-05 | 161 | 121 | 5 | 44f5c0256b3ce264a6c7b62740f32dcd45ee052d | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Club_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.81e-05 | 165 | 121 | 5 | 1a114eacaab598f755a173a3fed842ba91f689dd | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Club_cells-Airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.81e-05 | 165 | 121 | 5 | 9cfd3c1d2c6d714fde83b90465f1f9741b0e50ce | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC-pDC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.06e-05 | 166 | 121 | 5 | 9fa90d9d484563d44738bb2c6eb0775dffc4d549 | |
| ToppCell | Endothelial-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 9.32e-05 | 167 | 121 | 5 | 6a03d16165e0b003092c39972928981abd4a75aa | |
| ToppCell | Control-Epithelial_airway-Club_cells-Airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.59e-05 | 168 | 121 | 5 | ce87981f4da2779de952c2e5d2bbcdabb265e705 | |
| ToppCell | BAL-Control-cDC_6|Control / Compartment, Disease Groups and Clusters | 9.59e-05 | 168 | 121 | 5 | 65ec473cff748b334c0a66e33bc34a8465fe7631 | |
| ToppCell | ASK428-Immune-Mast_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.59e-05 | 168 | 121 | 5 | c399fcb4d1d0be48026c2ecabc34a5935e7adf73 | |
| ToppCell | Control-Epithelial_airway-Club_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.59e-05 | 168 | 121 | 5 | e85bc5398eb36b2b0773a8a7082e3ba740452165 | |
| ToppCell | COVID-19-lung-MAST|lung / Disease (COVID-19 only), tissue and cell type | 1.01e-04 | 170 | 121 | 5 | e90f18e5462381b38e918442b38b1c8105291908 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 171 | 121 | 5 | 6a0fafb8fd9fc7671618eeb2bf528ce8ce86b794 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.04e-04 | 171 | 121 | 5 | e6dfbd2652b67577c8834c05348f62150637f348 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.04e-04 | 171 | 121 | 5 | ddaeb96ce9c9c3bf232b4a42266fa2ee7e8f3f41 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 171 | 121 | 5 | e02b5831768dbb1b68998b672e55c9680ab0cc86 | |
| Drug | Amyleine hydrochloride [532-59-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 8.95e-06 | 194 | 120 | 8 | 4169_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; ssMCF7; HG-U133A | 1.00e-05 | 197 | 120 | 8 | 497_DN | |
| Drug | DL-PPMP; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 1.04e-05 | 198 | 120 | 8 | 1121_UP | |
| Disease | age of onset of multiple sclerosis | 1.40e-05 | 12 | 120 | 3 | OBA_2001029 | |
| Disease | carbamoyl phosphate synthetase I deficiency disease (implicated_via_orthology) | 1.64e-05 | 2 | 120 | 2 | DOID:9280 (implicated_via_orthology) | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 4.91e-05 | 3 | 120 | 2 | DOID:0111181 (implicated_via_orthology) | |
| Disease | migraine (implicated_via_orthology) | 9.79e-05 | 4 | 120 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | serum metabolite measurement | CACNA1E RAE1 HEATR4 TMEM233 HLCS CPS1 ADA CLMN PLA2G4A NCOA7 YWHAQ DOCK6 USP1 | 1.28e-04 | 945 | 120 | 13 | EFO_0005653 |
| Disease | Bipolar Disorder | 1.50e-04 | 477 | 120 | 9 | C0005586 | |
| Disease | chronic obstructive pulmonary disease, CC16 measurement | 2.43e-04 | 6 | 120 | 2 | EFO_0000341, EFO_0005080 | |
| Disease | hereditary ataxia (implicated_via_orthology) | 3.40e-04 | 7 | 120 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | glycosyl-N-(2-hydroxynervonoyl)-sphingosine (d18:1/24:1(2OH)) measurement | 4.52e-04 | 8 | 120 | 2 | EFO_0800533 | |
| Disease | Colorectal Carcinoma | CAD NRCAM MAP2 SYNE1 RTN4 ARFGEF1 JAKMIP2 ABCA5 MKI67 AGTPBP1 | 6.05e-04 | 702 | 120 | 10 | C0009402 |
| Disease | Asthma, Occupational | 7.23e-04 | 10 | 120 | 2 | C0264423 | |
| Disease | level of Phosphatidylinositol (18:1_18:1) in blood serum | 1.24e-03 | 13 | 120 | 2 | OBA_2045159 | |
| Disease | Liver Cirrhosis, Experimental | 1.27e-03 | 774 | 120 | 10 | C0023893 | |
| Disease | renal cell carcinoma (biomarker_via_orthology) | 1.45e-03 | 14 | 120 | 2 | DOID:4450 (biomarker_via_orthology) | |
| Disease | sphingosine 1-phosphate measurement | 2.40e-03 | 18 | 120 | 2 | EFO_0800185 | |
| Disease | polycystic kidney disease (biomarker_via_orthology) | 2.68e-03 | 19 | 120 | 2 | DOID:0080322 (biomarker_via_orthology) | |
| Disease | stomach cancer (is_marker_for) | 2.74e-03 | 142 | 120 | 4 | DOID:10534 (is_marker_for) | |
| Disease | hyperglycemia (biomarker_via_orthology) | 3.27e-03 | 21 | 120 | 2 | DOID:4195 (biomarker_via_orthology) | |
| Disease | level of Phosphatidylinositol (18:0_20:4) in blood serum | 3.92e-03 | 23 | 120 | 2 | OBA_2045158 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LDEPSTGMDPKAKQH | 1456 | Q8WWZ7 | |
| ALEQHLPDDDKTPMS | 116 | O00555 | |
| DQEITKADVETKPMP | 646 | Q5RHP9 | |
| QLESKKTEPEHRPMS | 591 | Q99814 | |
| STEHDPVLKQIDPEM | 466 | Q52LR7 | |
| EAFDISKKEMQPTHP | 151 | P27348 | |
| PDSELQPQDKVSEHM | 46 | P12645 | |
| MAQTPAFDKPKVELH | 1 | P00813 | |
| LALEQHLPEDDKTPM | 106 | Q15878 | |
| EAFEISKEQMQPTHP | 156 | Q04917 | |
| KKPTEDMCLTDHQPL | 821 | Q9UIF9 | |
| GQEKPSEQEMSEIKH | 641 | Q9Y6D6 | |
| DPDKHLGKTLDQMEP | 171 | Q7L8W6 | |
| KQITPRTEEEKMEHS | 161 | Q8WXI4 | |
| SVKTPKISMPDVDLH | 691 | Q09666 | |
| KGPKMDIDAPDVDVH | 2026 | Q09666 | |
| DLHLKAPKISMPEVD | 4121 | Q09666 | |
| PKIPVMKDDIEDSDS | 336 | Q9UKA4 | |
| AEDQKIHRPMAPKEA | 226 | Q9H467 | |
| ASKESPPHEDLMVQI | 121 | Q9UPW5 | |
| EKHPNSPMTAKQILE | 21 | Q9C0F0 | |
| TEHMKTPEEELQPES | 421 | Q8N0U7 | |
| ESKKMPIHFQEKEIP | 376 | Q8IWF9 | |
| HNPMKDIEVTSSPDD | 26 | P78406 | |
| PEENETKKESSVPMC | 421 | Q8N543 | |
| KENSEMREKITSHPP | 356 | Q96AA8 | |
| EEHVMKEKELVPEVP | 586 | P78559 | |
| HPKDESAMATAPIKN | 646 | Q96JE9 | |
| PESPTMLTKKPEDNH | 146 | Q9NQS7 | |
| LMKGEVDVTHDSEPK | 96 | Q9NV35 | |
| HFDIDKDPLVTMKPG | 86 | Q92823 | |
| KEKEDAHADPEIQPM | 1201 | Q92823 | |
| STNIPIDKEEEKPVM | 401 | Q14643 | |
| KKHLEINPDHPIMET | 496 | Q58FF7 | |
| EPSLEIKPEQDGMEH | 46 | P50747 | |
| EHVDKLKIPPEEMKQ | 171 | Q9Y6G9 | |
| EKMEPITKISHIPAS | 291 | Q9NQC1 | |
| IVHVGDKKPQPELEM | 676 | O15055 | |
| PKPAVDHDIDMKSEQ | 586 | Q14149 | |
| MHTPKPSVGEEKDII | 1296 | P46013 | |
| AMHTPKPAVGEEKDI | 1781 | P46013 | |
| LSKRHPDMKIEEVPE | 746 | Q9NQV6 | |
| ILEHMPVSNQKPDTD | 566 | Q9BUQ8 | |
| MEEEEEIPKPKSVVA | 51 | P15170 | |
| SDTEEEMPQVHTPKT | 711 | P25205 | |
| PESHLSNMKKPVEEG | 151 | Q9UP65 | |
| PEEMSLKEEKHENGP | 431 | Q9H7U1 | |
| KVMIGENVDEKHLPT | 1281 | P31327 | |
| KEEGVKSPQHVMAPT | 451 | Q9P2N4 | |
| SHNTVELMVVDKPPK | 406 | Q8N6C5 | |
| PKITGEEVSAEKMEH | 121 | A0A1W2PR19 | |
| ILTDTVKMKEHQEDP | 1561 | Q96HP0 | |
| APETMEDVGHPKTKD | 46 | O95873 | |
| CAKPSVTEEKNMEPE | 326 | Q9NQS1 | |
| TSHLPVAESPDMKKE | 176 | Q9NZC4 | |
| THPSVKGEKEENMLE | 476 | Q8N3K9 | |
| FPEEKPLEESKMVQS | 2096 | Q8N3K9 | |
| KGPEKSEMHREPADT | 771 | Q6ZU35 | |
| DESIMESIKHKVSEP | 766 | Q9HC77 | |
| EIMPGNKSTEDIHEK | 306 | Q86WZ0 | |
| EHLPVKPDTMEKLRT | 571 | Q8IWF6 | |
| PTEVKIQEMTKLGHE | 91 | Q99871 | |
| EALMEQQDPKSPSHK | 1006 | Q96PY5 | |
| DHMVKEPVEDTDPST | 21 | Q8WWZ3 | |
| TNVEHMIVDPPKKAL | 1161 | Q7Z589 | |
| KTHEMEPAEAIETPL | 226 | Q14527 | |
| KTEKEMHQPIPFTET | 1231 | Q8NDH2 | |
| VEENTPPKMEKEGLE | 571 | Q9NQC7 | |
| EMVENSTDPHPIKIT | 246 | Q12864 | |
| NKPDHMIKPVEVTES | 1031 | O15294 | |
| KNPDMEKDCPTIIHF | 626 | P47712 | |
| VPTHTNLELEPKADM | 251 | O15403 | |
| EMEELPVPHNIKISN | 46 | Q96FC7 | |
| MAKVEQPVPDHSELV | 721 | Q9NQC3 | |
| ELHSSPKLEMVKVEP | 381 | Q4G112 | |
| PEAQEEMKEVAKHPK | 521 | P07814 | |
| PSKCHELSPREVKEM | 161 | Q9UGI8 | |
| NTEDDKTEEDVPMPK | 21 | B4DJY2 | |
| HPPAVKEMKETQTER | 61 | Q6ZWK4 | |
| EKMVTPEDKASIPEN | 301 | A4FU49 | |
| HLITKESPQEEGKEM | 771 | Q8NF91 | |
| KKFVPHGDIPNMEDV | 406 | Q8N0V4 | |
| HMKIKDALPSDLPQD | 286 | Q8NI08 | |
| EKRPMPDSSHDVKVL | 511 | Q9HCM1 | |
| ELEPEMEPKAETETK | 881 | Q96RN1 | |
| LPPEVKHEILTDMKE | 196 | P28715 | |
| EPTDSVPKEQMSLVH | 466 | P28715 | |
| EEMPHKPQKDEDLTQ | 216 | Q9Y5N6 | |
| MERKELPPEHQSLKS | 1066 | Q9NQW1 | |
| LPVEVPSKQEEKHMT | 51 | P07476 | |
| DTDPLVTVMKVEKAP | 166 | P62191 | |
| EAFEISKKEMQPTHP | 151 | P63104 | |
| KDPKVEMRVPDVEVS | 2101 | Q8IVF2 | |
| EPQVKMDKHEPHQDS | 621 | Q96JQ2 | |
| PKEEKVAMHAPLAVS | 321 | Q9NQ32 | |
| AQKEDMPPEHVRKII | 56 | Q6P2Q9 | |
| VPEEHPKDKKDFIDM | 606 | Q8IWX7 | |
| QQTLEAHMKEKHPEP | 656 | Q86UP3 | |
| TTEELHKYQKMLEPP | 706 | O95235 | |
| KKEEETPNHAAEAMP | 46 | Q5TAB7 | |
| NSEESEKEKSPLMHP | 436 | O95759 | |
| EKEKSPLMHPDALVT | 441 | O95759 | |
| TPPTMEEILKNEKHR | 81 | Q8N183 | |
| DESVSKEQHMIPSPI | 771 | Q12968 | |
| GEESVKKPQTLMELH | 476 | O95391 | |
| EDSNSHSLKKDPVMP | 561 | A0A0J9YWL9 | |
| EIKDIHVPPRVKESM | 176 | Q9UJZ1 | |
| TVEIPKKMENPHSLL | 306 | Q9NQ25 | |
| NHPDADAPEVVSVMK | 1351 | Q6AHZ1 | |
| HLNDPQPIEMTVKKT | 1791 | Q14997 | |
| PPQKHALSDIADMVK | 786 | Q9NRE2 | |
| DHTVKPVSDMELETP | 791 | P27708 | |
| HLPIPTKNMLEESKV | 1806 | Q9BYW2 | |
| EAMTLPKDAHIPVVE | 386 | P11137 | |
| METISQDPEHKGPKE | 321 | Q9UJA5 | |
| THPKKEPMEALNTAQ | 56 | Q6PI78 | |
| VEIHLESSDKEKPVM | 446 | Q8WYQ9 | |
| NPDTMETEKPKTITE | 751 | Q86T82 | |
| IPPELEEEVKEIMKH | 1666 | O60346 | |
| SMPHKPVSDKLSEEV | 821 | Q9ULL1 | |
| HMKTPTEEKPYECKE | 241 | Q32M78 | |
| MVDPKKEADHEIPTV | 621 | Q9UN76 | |
| LEATEKSIGPPEMHK | 196 | Q8IY18 | |
| SDVNIDIKFPPKMNH | 411 | Q5TAX3 | |
| KQEVSEEMEPHGKTS | 196 | O43309 | |
| PKMEVRAEEPKEATE | 71 | A6NL46 | |
| TKVEEIPHPKEEMNG | 231 | O94782 | |
| AKGDHPETIMEEVKI | 836 | Q6EMB2 | |
| ALSPVDMEPEKLVHK | 656 | Q96SB3 | |
| EDVKHKYTMSPDLPQ | 1266 | P20929 | |
| KDKTQIHIMPDTPDI | 2486 | P20929 | |
| DKDKTQIHIMPDTPE | 2971 | P20929 | |
| LEPPEVKHAMEVAKK | 5706 | P20929 |